Axelife's research contributes to the advancement of knowledge in the field of arterial stiffness and its consequences on numerous pathologies.

Over the past 10 years, Axelife has developed algorithms for pulse wave analysis, notably to determine vascular age, PWV, ABI and screen for PAOD, and is currently working on other biomarkers, notably in diabetes.